MILANI PHILIP: Open Payments
NPI 1285195784 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$199 in 10 payments from 4 companies in 2025. Trend: 2023 $17 · 2024 $194 · 2025 $199
Food & beverage: $199
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $147 |
| Astellas Pharma US Inc | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
| Acella Pharmaceuticals, LLC | 1 | $14 |
Products named: Wegovy, Ozempic, Veozah, Rybelsus, XIFAXAN, NP Thyroid 60.
Industry payments across IL — which companies pay providers there.
